You searched for "blink"
Applanation tonometry in the pandemic era: Are facial masks an obstacle to a correct intraocular pressure measurement?
6 January 2021
| Karishma Parmar, Chung Shen Chean, Tristan McMullan
|
EYE - Glaucoma, EYE - General
Current recommendations in the UK advise on wearing any facial covering to prevent the spread of the coronavirus [1]. Whilst this is vital for patient and hospital staff safety, it has led to several changes in the approach to a...
How the other half live – ophthalmology training around the world
5 August 2020
| Hari Kaneshayogan
|
EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - Cornea, EYE - General
Ophthalmology speciality training is currently seven years in the UK without an additional fellowship. UK trainees are privileged to have a training programme that is held in high esteem across the world, but did you ever wonder what other trainees...
Retinoblastoma management update (part 1): clinical features, diagnosis and genetics
1 January 2017
| Manoj V Parulekar
|
EYE - Oncology
The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
Optegra celebrates 15th anniversary and announces expansion plans
Specialist eye hospital Optegra marks its 15th anniversary this month, having opened its first UK hospital in Guildford in 2008.Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
29 March 2023
|
glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
The management of retinal vein occlusions: a summary
1 February 2015
| Amy-lee Shirodkar
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...
The results of the last survey Jun 2020
Firstly, my sincere thanks to those of you who responded to last edition’s survey. We had a record response. Laser was never my most exciting clinical treatment, but in this environment how I wish for even that degree of patient...Strabismus in thyroid eye disease
Pathogenesis Thyroid eye disease (TED) is an auto-immune condition, in the initial phase there is lymphocytic infiltration and oedema of the extraocular muscles with deposition of glycosaminoglycans and hyaluronic acid and adipogenesis, which can lead to an increase in the...Training the trainers
1 February 2015
| Gwyn Samuel Williams
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Neuro-ophthalmology, EYE - Imaging, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Learning phakoemulsification is a psychologically demanding process. Every ophthalmologist passing through the UK training system will almost certainly have many stories to tell of difficulties faced along the way; hideous disasters where lessons were learnt, as well as glorious triumphs...
